Reports Q2 revenue $83M, consensus $71.82M. “We’re building a stronger, more competitive company defined by continued momentum in Canada adult-use cannabis, consistent growth in Canada medical cannabis, and a disciplined approach to strengthening our balance sheet. Together, these actions give me confidence in our ability to sustain progress and deliver results for quarters to come,” said Luc Mongeau, CEO.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGC:
- Options Volatility and Implied Earnings Moves Today, November 07, 2025
- These Are the Stocks Reporting Earnings Today – November 7, 2025
- CGC Upcoming Earnings Report: What to Expect?
- Options Volatility and Implied Earnings Moves This Week, November 03 – November 07, 2025
- Canopy Growth to Announce Q2 Fiscal 2026 Financial Results